How can doctors discuss CLL treatment options with patients?
Can the cytomegalovirus be predicted by ELISpot assays?
AML immunotherapy: pre-clinical data to look forward to at ASH 2017
Using models to predict progression in follicular lymphoma
T-cell engaging antibodies: what lessons have we learnt?